Tumor growth significantly decreased in Ad-PPTLS-APE1/Ref-1-injected mice compared with ASA-treated, Ad-β-galactosidase, or Ad-APE1/Ref-1-injected mice (Figure 3A,B). The gene discussed is APEX1; the disease is neoplasm.